The levels and predictors of physical activity engagement within the treatment seeking transgender population: a matched control study

Background: Physical activity has been found to alleviate mental health problems and could be beneficial for at-risk populations, such as transgender people. This study had three aims. First, to explore the amount of physical activity that treatment seeking transgender people engage in, and to compare this to matched cisgender people. Second, to determine whether there was a difference in physical activity depending on cross-sex hormone use. Third, to determine factors which predict physical activity among treatment seeking transgender people. Method: Transgender (n=360) and cisgender people (n=314) were recruited from the UK. Participants were asked to complete questionnaires about physical activity, symptoms of anxiety and depression, self-esteem, body satisfaction and transphobia. Results: Transgender people engaged in less physical activity than cisgender people. Transgender people who were on cross-sex hormones engaged in more physical activity than transgender people who were not. In transgender people on cross-sex hormones, high body satisfaction was the best statistical predictor of physical activity while high self-esteem was the best statistical predictor in people who were not. Conclusion: Transgender people are less active than cisgender people. Cross-sex hormone treatment appears to be able to indirectly increase physical activity within this population, which may be beneficial for mental well-being

Sociodemographic variables, clinical features, and the role of preassessment cross-sex hormones in older trans people

Introduction: As referrals to gender identity clinics have increased dramatically over the last few years, no studies focusing on older trans people seeking treatment are available. Aims: The aim of this study was to investigate the sociodemographic and clinical characteristics of older trans people attending a national service and to investigate the influence of cross-sex hormones (CHT) on psychopathology. Methods: Individuals over the age of 50 years old referred to a national gender identity clinic during a 30-month period were invited to complete a battery of questionnaires to measure psychopathology and clinical characteristics. Individuals on cross-sex hormones prior to the assessment were compared with those not on treatment for different variables measuring psychopathology. Main Outcome Measures: Sociodemographic and clinical variables and measures of depression and anxiety (Hospital Anxiety and Depression Scale), self-esteem (Rosenberg Self-Esteem Scale), victimization (Experiences of Transphobia Scale), social support (Multidimensional Scale of Perceived Social Support), interpersonal functioning (Inventory of Interpersonal Problems), and nonsuicidal self-injury (Self-Injury Questionnaire). Results: The sex ratio of trans females aged 50 years and older compared to trans males was 23.7:1. Trans males were removed for the analysis due to their small number (n ¼ 3). Participants included 71 trans females over the age of 50, of whom the vast majority were white, employed or retired, and divorced and had children. Trans females on CHT who came out as trans and transitioned at an earlier age were significantly less anxious, reported higher levels of self-esteem, and presented with fewer socialization problems. When controlling for socialization problems, differences in levels of anxiety but not self-esteem remained. Conclusion: The use of cross-sex hormones prior to seeking treatment is widespread among older trans females and appears to be associated with psychological benefits. Existing barriers to access CHT for older trans people may need to be re-examined

Schizophrénie et dysfonctions sexuelles

AIX-MARSEILLE2-BU Méd/Odontol. (130552103) / SudocSudocFranceF

Maintenance of a positive image of oneself starting from the mechanism of emotional repression of the transsexuals

International audienc

Trouble de l’identité de genre: quel est le rôle du psychiatre ?

National audienceAu-delà du débat sur l’étiologie des troubles de l’identité de genre (TIG), le rôle du psychiatre dans la prise en charge des transsexuels est fondamental. En effet, quelle que soit l’origine des TIG, toutes les études montrent que le succès de la réassignation sexuelle par traitement hormonochirurgical (THC) dépend de la qualité de la démarche diagnostique et de facteurs psychiques et/ou psychopathologiques qu’il faut avoir dépistés et pris en charge. Le rôle du psychiatre dans la prise en charge des dysphorie de genre consiste à : confirmer le diagnostic de trouble de l’i dentitéd de genre ; éliminer un éventuel diagnostic différentiel des troublesdel’identitédegenre ; dépister et traiter d’éventuelles comorbidités psychiatriques ; détecter et informer le patient des facteurs prédictifs positifs et négatifs le concernant et discuter des bénéfices/risques d’une conversion chirurgicale ; repérer les attentes irréalistes pour éviter des frustrations et des déceptions inadaptées qui vont retentir sur l’équipe chirurgicale. Les objectifs dupsychiatre vis-a-vis des patients : prévenir d’éventuelles complications psychosociales du traitement hormonochirurgical et optimiser les chances d’une transformation réussie, en termes de satisfaction globale du patient et d’adaptation psychosociale au nouveau genre. Des études réalisées sur le devenir des transsexuels opérés montrent que 2 % d’entre eux présentent des regrets définitifs quant à la transformation, 10 % expriment des regrets transitoires. Les taux de dépressions sévères et de décès par suicide sont significativement supérieurs à ceux de la population générale. L’évaluation psychiatrique permet de dépister les patients vulnérables et à leur proposer une prise en charge adaptée et personnalisée avant tout recours chirurgical. Les objectifs du psychiatre vis-à-vis de l ’équipe de genre : des facteurs psychologiques prédictifs d’une évolution péjorative des troubles après conversion sexuelle ont été mis en évidence par des travaux rétro- et prospectifs. Pour chaque patient, ces éléments pronostiques doivent être discutés en équipe afin que la décision de traitement hormonochirurgical (THC) soit l’objet d’une information éclairée tant du patient que de l’équipe soignante et particulièrement du chirurgien qui peut être confronté à des regrets ou des revendications résultant d’une évaluation globale insuffisante. Même si ces facteurs de vulnérabilité ne constituent pas en eux-mêmes des contre-indications à la conversion sexuelle, ils doivent inciter à la prudence et permettre au chirurgien d’évaluer les répercussions de son geste

MMPI-2 Profile of French Transsexuals: The Role of Sociodemographic and ă Clinical Factors. A cross-sectional design

International audienceThe assessment of co-existing psychological and psychiatric disorders is ă advocated in the Standards of Care for the health of transsexual people. ă This study aimed to determine the psychopathological characteristics of ă transsexuals based on a large sample of French individuals and to ă identify whether these characteristics differed according to the ă individual's sociodemographic or clinical characteristics. The aim of ă this study was to determine the psychopathological characteristics of ă transsexuals from a large sample of French individuals and whether these ă differed by sociodemographic or clinical characteristics. This ă cross-sectional study was conducted in a French public university ă hospital. The inclusion criteria were 18 years or older, diagnosis of ă gender dysphoria, and eligibility for a standardized sex reassignment ă procedure. Personality characteristics were assessed using the Minnesota ă Multiphasic Personality Inventory 2 (MMPI-2). A total of 108 individuals ă provided a valid MMPI-2 between January 2007 and December 2010. The ă final sample had a median age of 31 years and included 54 (50%) ă Female-to-Male individuals. In multivariate models, hormonal therapy ă status was significantly related to the scales of MMPI-2 (Psychasthenia ă and Masculinity/Femininity). Personality assessment can help a ă multidisciplinary gender dysphoria team detect potential ă psychopathological factors of vulnerability